From Chemistry Passion to Clinical Impact: How CROs Must Evolve to Power the Next Generation of Biotech Innovation

Dr. Peter M. Kovacs interviews Jiri Raska of Quinta Analytica on how CROs support biotech startups through biologics, bioequivalence trials, ADC analytics, and Europe’s evolving clinical trial regulations.